Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Ironwood Pharmaceuticals, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 11 months agoironwoodpharma.com
Ironwood Pharmaceuticals, Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative treatments for gastrointestinal diseases. Founded in 1998, Ironwood has made significant strides in the industry, particularly with its flagship product, Linzess (linaclotide), which addresses irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).
With a strong presence in the US and expanding operations in key international markets, Ironwood is dedicated to improving patient outcomes through its unique approach to drug development. The company has established itself as a notable player in the gastrointestinal sector, leveraging its expertise to deliver effective therapies that meet unmet medical needs. Ironwood's commitment to innovation and patient care continues to drive its success in the competitive biopharmaceutical landscape.
23
DitchCarbon score
-19 vs industry average
Ironwood Pharmaceuticals, Inc.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ironwood Pharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Ironwood Pharmaceuticals, Inc. yet.
Ironwood Pharmaceuticals, Inc.'s reported carbon emissions
Ironwood Pharmaceuticals, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Ironwood Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it remains essential for companies like Ironwood to consider developing and communicating their climate strategies to align with global efforts in reducing greenhouse gas emissions.
Assessing Ironwood Pharmaceuticals, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Ironwood Pharmaceuticals, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Ironwood Pharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Ironwood Pharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Ironwood Pharmaceuticals, Inc.11 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more